Another group analysed serum hepcidin levels in multiple sclerosis (MS) in relapsing and progressive patients (active vs. inactive subjects, n = 71) and compared with healthy controls (n = 16) [85]. The gene discussed is HAMP; the disease is myeloid sarcoma.